Innovative 'drug-factory' implants effectively target various cancers
Scientists have developed tiny implants called cytokine factories that produce immune-stimulating proteins directly at tumor sites, significantly improving cancer treatment efficacy and reducing side effects. These implants have shown promising results in animal studies for various cancers, including ovarian, colorectal, and mesothelioma, and are moving toward human clinical trials, with potential applications for other immune-related conditions.